Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 4,847

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)

Wang, Jiang, Sánchez-Roselló, María, Aceña, José Luis, del Pozo, Carlos, Sorochinsky, Alexander E., Fustero, Santos, Soloshonok, Vadim A., Liu, Hong·2014·Chemical Reviews
DOI 10.1021/cr4002879
Open this paper in CoChat — free account

Abstract

ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTFluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)Jiang Wang†, María Sánchez-Roselló‡§, José Luis Aceña∥, Carlos del Pozo‡, Alexander E. Sorochinsky∥⊥#, Santos Fustero*‡§, Vadim A. Soloshonok*∥⊥, and Hong Liu*†View Author Information† Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China‡ Department of Organic Chemistry, Faculty of Pharmacy, University of Valencia, Av. Vicente Andrés Estellés, 46100 Burjassot, Valencia, Spain§ Laboratorio de Moléculas Orgánicas, Centro de Investigación Príncipe Felipe, C/ Eduardo Primo Yúfera 3, 46012 Valencia, Spain∥ Department of Organic Chemistry I, Faculty of Chemistry, University of the Basque Country UPV/EHU, Paseo Manuel Lardizábal 3, 20018 San Sebastian, Spain⊥ IKERBASQUE, Basque Foundation for Science, Alameda Urquijo, 36-5 Plaza Bizkaia, 48011 Bilbao, Spain# Institute of Bioorganic Chemistry and Petrochemistry, National Academy of Sciences of Ukraine, Murmanska Street 1, 02660 Kyiv-94, Ukraine*E-mail: [email protected]*E-mail: [email protected]*E-mail: [email protected]Cite this: Chem. Rev. 2014, 114, 4, 2432–2506Publication Date (Web):December 3, 2013Publication History Received27 May 2013Published online3 December 2013Published inissue 26 February 2014https://pubs.acs.org/doi/10.1021/cr4002879https://doi.org/10.1021/cr4002879review-articleACS PublicationsCopyright © 2013 American Chemical SocietyRequest reuse permissionsArticle Views48704Altmetric-Citations3850LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Anions,Fluorine,Organic compounds,Pharmaceuticals,Reaction products Get e-Alerts

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/cr4002879

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 538

  1. Christe K. O., 1986, Inorg. Chem., 25, 3721, 10.1021/ic00241a001 · doi:10.1021/ic00241a001
  2. Moissan H., 1896, C. R. Hebd. Acad. Sci., 128, 1543
  3. Ruff O., 1930, Z. Anorg. Allg. Chem., 190, 270, 10.1002/zaac.19301900127 · doi:10.1002/zaac.19301900127
  4. Hiyama H., 2000, Organofluorine Compounds: Chemistry and Applications, 10.1007/978-3-662-04164-2 · DOI · Paper page
  5. Baasner B., 2000, Houben-Weyl Methods of Organic Chemistry, 10
  6. Fried J., 1953, J. Am. Chem. Soc., 75, 2273, 10.1021/ja01105a527 · DOI
  7. Fried J., 1954, J. Am. Chem. Soc., 76, 1455, 10.1021/ja01634a101 · DOI · Paper page
  8. Ojima I., 2009, Fluorine in Medicinal Chemistry and Chemical Biology, 10.1002/9781444312096 · DOI · Paper page
  9. Ojima I., 2013, J. Org. Chem., 78, 6358, 10.1021/jo400301u · DOI · Paper page
  10. Carter G. T., 2011, Nat. Prod. Rep., 28, 1783, 10.1039/c1np00033k · DOI
  11. Marais J. S. C., 1943, Onderstepoort J. Vet. Sci. Anim. Ind., 18, 203
  12. Marais J. S. C., 1944, Onderstepoort J. Vet. Sci. Anim. Ind., 20, 67
  13. O’Hagan D., 1999, J. Fluorine Chem., 100, 127, 10.1016/S0022-1139(99)00201-8 · DOI · Paper page
  14. O’Hagan D., 2002, Nature, 416, 279, 10.1038/416279a · DOI · Paper page
  15. Dong C., 2004, Nature, 427, 561, 10.1038/nature02280 · DOI · Paper page
  16. Sanada M., 1986, J. Antibiot., 39, 259, 10.7164/antibiotics.39.259 · DOI · Paper page
  17. Gribble G. W., 2004, J. Chem. Educ., 81, 1441, 10.1021/ed081p1441 · doi:10.1021/ed081p1441
  18. Zhan C.-G., 2004, J. Phys. Chem. A, 108, 2020, 10.1021/jp0311512 · DOI · Paper page
  19. Sitachitta N., 1998, J. Am. Chem. Soc., 120, 7131, 10.1021/ja9811389 · DOI
  20. O’Hagan D., 2008, Chem. Soc. Rev., 37, 308, 10.1039/B711844A · DOI · Paper page
  21. Fuchikami T., 1982, Tetrahedron Lett., 23, 4099, 10.1016/S0040-4039(00)88357-4 · doi:10.1016/s0040-4039(00)88357-4
  22. Ojima I., 1987, J. Am. Chem. Soc., 109, 7714, 10.1021/ja00259a020 · doi:10.1021/ja00259a020
  23. Ojima I., 1988, J. Am. Chem. Soc., 110, 150, 10.1021/ja00209a024 · doi:10.1021/ja00209a024
  24. Ojima I., 1989, J. Org. Chem., 54, 4511, 10.1021/jo00280a014 · doi:10.1021/jo00280a014
  25. Soloshonok V. A., 1996, Tetrahedron, 52, 12433, 10.1016/0040-4020(96)00741-7 · DOI
  26. Soloshonok V. A., 1994, Tetrahedron Lett., 35, 5063, 10.1016/S0040-4039(00)73320-X · doi:10.1016/s0040-4039(00)73320-x
  27. Katagiri T., 2001, Chem. Commun., 2054, 10.1039/b105602f · doi:10.1039/b105602f
  28. Fuchikami T., 1982, J. Am. Chem. Soc., 104, 3527, 10.1021/ja00376a057 · doi:10.1021/ja00376a057
  29. Fuchikami T., 1983, J. Org. Chem., 48, 3803, 10.1021/jo00169a040 · doi:10.1021/jo00169a040
  30. Ojima I., 1988, J. Am. Chem. Soc., 110, 5617, 10.1021/ja00225a004 · doi:10.1021/ja00225a004
  31. Soloshonok V. A., 1994, Tetrahedron Lett., 35, 2713, 10.1016/S0040-4039(00)77013-4 · doi:10.1016/s0040-4039(00)77013-4
  32. Soloshonok V. A., 1994, Tetrahedron: Asymmetry, 5, 1091, 10.1016/0957-4166(94)80059-6 · doi:10.1016/0957-4166(94)80059-6
  33. Peters, R.Proceedings of the Ciba Foundation Symposium on Carbon-Fluorine Compounds: Chemistry,Biochemistry, and Biological Activities;Elsevier:Amsterdam, 1972; pp55–76. · DOI
  34. Purser S., 2008, Chem. Soc. Rev., 37, 320, 10.1039/B610213C · DOI · Paper page
  35. Kobzev S. V., 1989, Zh. Obshch. Khim., 59, 909
  36. Van Niel M. B., 1999, J. Med. Chem., 42, 2087, 10.1021/jm981133m · doi:10.1021/jm981133m
  37. Rowley M., 2001, J. Med. Chem., 44, 1603, 10.1021/jm0004998 · DOI
  38. Morgenthaler M., 2007, ChemMedChem, 2, 1100, 10.1002/cmdc.200700059 · DOI · Paper page
  39. Sparr C., 2009, Angew. Chem., Int. Ed., 48, 3065, 10.1002/anie.200900405 · doi:10.1002/anie.200900405
  40. Soloshonok V. A., 1994, Tetrahedron Lett., 35, 1055, 10.1016/S0040-4039(00)79964-3 · DOI
  41. Soloshonok V. A., 1996, Tetrahedron: Asymmetry, 7, 1547, 10.1016/0957-4166(96)00177-2 · doi:10.1016/0957-4166(96)00177-2
  42. Bohm H.-J., 2004, ChemBioChem, 5, 637, 10.1002/cbic.200301023 · DOI · Paper page
  43. Isanbor C., 2006, J. Fluorine Chem., 127, 303, 10.1016/j.jfluchem.2006.01.011 · DOI · Paper page
  44. Begue J.-P., 2006, J. Fluorine Chem., 127, 992, 10.1016/j.jfluchem.2006.05.006 · DOI · Paper page
  45. Kirk K. L., 2006, J. Fluorine Chem., 127, 1013, 10.1016/j.jfluchem.2006.06.007 · DOI · Paper page
  46. Müller K., 2007, Science, 317, 1881, 10.1126/science.1131943 · DOI · Paper page
  47. Hagmann W. K., 2008, J. Med. Chem., 51, 4359, 10.1021/jm800219f · DOI · Paper page
  48. O’Hagan D., 2010, J. Fluorine Chem., 131, 1071, 10.1016/j.jfluchem.2010.03.003 · DOI · Paper page
  49. Jordan V. C., 2003, J. Med. Chem., 46, 1081, 10.1021/jm020450x · DOI · Paper page
  50. Wakeling A. E., 1991, Cancer Res., 51, 3867
  51. Wakeling A. E., 2000, Endocr.-Relat. Cancer, 7, 17, 10.1677/erc.0.0070017 · DOI · Paper page
  52. Agouridas V., 2009, J. Med. Chem., 52, 883, 10.1021/jm801154q · DOI
  53. Brazier E. J., 2010, Org. Process Res. Dev., 14, 544, 10.1021/op900315j · doi:10.1021/op900315j
  54. Hogan P. J., 2010, Org. Process Res. Dev., 14, 1188, 10.1021/op1001319 · DOI
  55. D’Incecco A., 2011, Expert Opin. Drug Saf., 10, 987, 10.1517/14740338.2011.617738 · DOI
  56. Ranson M., 2002, J. Clin. Oncol., 20, 2240, 10.1200/JCO.2002.10.112 · DOI · Paper page
  57. Cohen M. H., 2004, Clin. Cancer Res., 10, 1212, 10.1158/1078-0432.CCR-03-0564 · DOI · Paper page
  58. Sordella R., 2004, Science, 305, 1163, 10.1126/science.1101637 · DOI · Paper page
  59. Barker A. J., 2001, Bioorg. Med. Chem. Lett., 11, 1911, 10.1016/S0960-894X(01)00344-4 · DOI · Paper page
  60. Ballard P., 2006, Bioorg. Med. Chem. Lett., 16, 4908, 10.1016/j.bmcl.2006.06.054 · doi:10.1016/j.bmcl.2006.06.054
  61. 1996, Chem. Abstr., 126, 47235
  62. 2004, Chem. Abstr., 140, 287403
  63. Wang J. Q., 2006, Bioorg. Med. Chem. Lett., 16, 4102, 10.1016/j.bmcl.2006.04.080 · DOI
  64. Chandregowda V., 2007, Org. Process Res. Dev., 11, 813, 10.1021/op700054p · doi:10.1021/op700054p
  65. Wilhelm S., 2006, Nat. Rev. Drug Discovery, 5, 835, 10.1038/nrd2130 · DOI · Paper page
  66. Wilhelm S. M., 2008, Mol. Cancer Ther., 7, 3129, 10.1158/1535-7163.MCT-08-0013 · DOI · Paper page
  67. Collins I., 2006, Nat. Chem. Biol., 2, 689, 10.1038/nchembio840 · DOI · Paper page
  68. Wilhelm S. M., 2004, Cancer Res., 64, 7099, 10.1158/0008-5472.CAN-04-1443 · DOI · Paper page
  69. Dietrich J., 2010, Bioorg. Med. Chem., 18, 5738, 10.1016/j.bmc.2010.05.063 · DOI · Paper page
  70. Bankston D., 2002, Org. Process Res. Dev., 6, 777, 10.1021/op020205n · DOI
  71. Breitler S., 2011, Org. Lett., 13, 3262, 10.1021/ol201210t · doi:10.1021/ol201210t
  72. Rawling T., 2012, Tetrahedron, 68, 6065, 10.1016/j.tet.2012.05.002 · doi:10.1016/j.tet.2012.05.002
  73. Walko C. M., 2005, Clin. Ther., 27, 23, 10.1016/j.clinthera.2005.01.005 · DOI · Paper page
  74. Wagstaff A. J., 2003, Drugs, 63, 217, 10.2165/00003495-200363020-00009 · doi:10.2165/00003495-200363020-00009
  75. McGavin J. K., 2001, Drugs, 61, 2309, 10.2165/00003495-200161150-00015 · doi:10.2165/00003495-200161150-00015
  76. Koukourakis G. V., 2008, Molecules, 13, 1897, 10.3390/molecules13081897 · doi:10.3390/molecules13081897
  77. Malet-Martino M., 2002, Oncologist, 7, 288, 10.1634/theoncologist.7-4-288 · DOI · Paper page
  78. Ishitsuka H., 1999, J. Pharm. Soc. Jpn., 119, 881, 10.1248/yakushi1947.119.12_881 · doi:10.1248/yakushi1947.119.12_881
  79. Kratz F., 2008, ChemMedChem, 3, 20, 10.1002/cmdc.200700159 · DOI · Paper page
  80. Shimma N., 2000, Bioorg. Med. Chem., 8, 1697, 10.1016/S0968-0896(00)00087-0 · doi:10.1016/s0968-0896(00)00087-0
  81. 1981, Chem. Abstr., 95, 62602
  82. Niedballa U., 1974, J. Org. Chem., 39, 3654, 10.1021/jo00939a008 · doi:10.1021/jo00939a008
  83. Saneyoshi M., 1978, Chem. Pharm. Bull., 26, 2990, 10.1248/cpb.26.2990 · doi:10.1248/cpb.26.2990
  84. Shen B., 2012, Org. Lett., 14, 3348, 10.1021/ol301324g · DOI
  85. Polyzos A., 2008, J. Steroid Biochem. Mol. Biol., 108, 261, 10.1016/j.jsbmb.2007.09.004 · DOI
  86. Faivre S., 2007, Nat. Rev. Drug Discovery, 6, 734, 10.1038/nrd2380 · DOI · Paper page
  87. Laderoute K. R., 2010, Cancer Biol. Ther., 10, 68, 10.4161/cbt.10.1.12162 · DOI
  88. Mendel D. B., 2003, Clin. Cancer Res., 9, 327
  89. Sun L., 2003, J. Med. Chem., 46, 1116, 10.1021/jm0204183 · DOI · Paper page
  90. Manley J. M., 2003, J. Org. Chem., 68, 6447, 10.1021/jo034304q · doi:10.1021/jo034304q
  91. Wang J.-Q., 2005, Bioorg. Med. Chem. Lett., 15, 4380, 10.1016/j.bmcl.2005.06.038 · doi:10.1016/j.bmcl.2005.06.038
  92. Tiwari A. K., 2009, Biochem. Pharmacol., 78, 153, 10.1016/j.bcp.2009.04.002 · DOI · Paper page
  93. Verstovsek S., 2006, Leuk. Res., 30, 1499, 10.1016/j.leukres.2006.03.012 · DOI
  94. Weisberg E., 2006, Br. J. Cancer, 94, 1765, 10.1038/sj.bjc.6603170 · DOI · Paper page
  95. Davies J., 2011, Lancet Oncol., 12, 826, 10.1016/S1470-2045(11)70228-5 · doi:10.1016/s1470-2045(11)70228-5
  96. Weisberg E., 2005, Cancer Cell., 7, 129, 10.1016/j.ccr.2005.01.007 · DOI · Paper page
  97. Deadman B. J., 2013, Org. Biomol. Chem., 11, 1766, 10.1039/C2OB27003J · DOI
  98. Manley P. W., 2010, Bioorg. Med. Chem., 18, 6977, 10.1016/j.bmc.2010.08.026 · DOI
  99. 2004, Chem. Abstr., 140, 77161
  100. Huang W.-S., 2007, Synthesis, 2121, 10.1055/s-2007-983754 · doi:10.1055/s-2007-983754
  101. Ueda S., 2012, J. Am. Chem. Soc., 134, 700, 10.1021/ja2102373 · doi:10.1021/ja2102373
  102. Moy B., 2007, Nat. Rev. Drug Discovery, 6, 431, 10.1038/nrd2332 · DOI
  103. Geyer C., 2006, N. Engl. J. Med., 355, 2733, 10.1056/NEJMoa064320 · DOI · Paper page
  104. Burris H. A., 2004, Oncologist, 9, 10, 10.1634/theoncologist.9-suppl_3-10 · DOI · Paper page
  105. Lackey K. E., 2006, Curr. Top. Med. Chem., 6, 435, 10.2174/156802606776743156 · DOI
  106. Wenle X., 2002, Oncogene, 21, 6255, 10.1038/sj.onc.1205794 · DOI · Paper page
  107. Johnston S. R. D., 2006, Drugs Today, 42, 441, 10.1358/dot.2006.42.7.985637 · DOI
  108. Huang Y., 2012, Biochemistry, 51, 2390, 10.1021/bi2016553 · DOI
  109. Wood E. R., 2004, Cancer Res., 64, 6652, 10.1158/0008-5472.CAN-04-1168 · DOI · Paper page
  110. Basuli F., 2011, J. Labelled Compd. Radiopharm., 54, 633, 10.1002/jlcr.1898 · doi:10.1002/jlcr.1898
  111. Petrov K. G., 2006, Bioorg. Med. Chem. Lett., 16, 4686, 10.1016/j.bmcl.2006.05.090 · DOI
  112. Wood E. R., 2004, Cancer Res., 64, 6652, 10.1158/0008-5472.CAN-04-1168 · DOI · Paper page
  113. 2002, Chem. Abstr., 137, 119644
  114. Mahboobi S., 2010, J. Med. Chem., 53, 8546, 10.1021/jm100665z · DOI
  115. Underiner T. L., 2010, Anticancer Agents Med. Chem., 10, 7, 10.2174/1871520611009010007 · DOI
  116. Christensen J. G., 2005, Cancer Lett., 225, 1, 10.1016/j.canlet.2004.09.044 · DOI · Paper page
  117. Comoglio P. M., 2002, J. Clin. Invest., 109, 857, 10.1172/JCI0215392 · DOI
  118. Mazzone M., 2006, FASEB J., 20, 1611, 10.1096/fj.06-5947rev · DOI
  119. Sattler M., 2009, Update Cancer Ther., 3, 109, 10.1016/j.uct.2009.01.001 · DOI
  120. Galetta D., 2012, Expert Opin. Ther. Targets, 16, S45, 10.1517/14728222.2011.642372 · DOI
  121. Kruczynski A., 2012, Expert Opin. Ther. Targets, 16, 1127, 10.1517/14728222.2012.719498 · DOI
  122. Tothova Z., 2012, Curr. Opin. Oncol., 24, 409, 10.1097/CCO.0b013e328354c155 · DOI
  123. Mologni L., 2012, Expert Opin. Investig. Drugs, 21, 985, 10.1517/13543784.2012.690031 · DOI
  124. Zhong W. Z., 2010, Curr. Drug Metab., 11, 296, 10.2174/138920010791514207 · doi:10.2174/138920010791514207
  125. Tanizaki J., 2011, J. Thorac. Oncol., 6, 1624, 10.1097/JTO.0b013e31822591e9 · DOI
  126. Pennell N. A., 2012, Am. J. Manag. Care, 18, SP84
  127. Girard N., 2012, Lancet Oncol., 13, 962, 10.1016/S1470-2045(12)70375-3 · DOI
  128. Okamoto W., 2012, Mol. Cancer Ther., 11, 1557, 10.1158/1535-7163.MCT-11-0934 · DOI
  129. Smolen G. A., 2006, Proc. Natl. Acad. Sci. U.S.A., 103, 2316, 10.1073/pnas.0508776103 · DOI · Paper page
  130. Ma P. C., 2005, Clin. Cancer Res., 11, 2312, 10.1158/1078-0432.CCR-04-1708 · DOI
  131. Cui J. J., 2011, J. Med. Chem., 54, 6342, 10.1021/jm2007613 · DOI · Paper page
  132. 2006, Chem. Abstr., 144, 274297
  133. Ramachandran P. V., 2004, Tetrahedron Lett., 45, 2603, 10.1016/j.tetlet.2004.01.146 · doi:10.1016/j.tetlet.2004.01.146
  134. Trost B. M., 1986, J. Org. Chem., 51, 2370, 10.1021/jo00362a036 · DOI · Paper page
  135. de Koning P. D., 2011, Org. Process Res. Dev., 15, 1018, 10.1021/op200131n · DOI
  136. Tsai J., 2008, Proc. Natl. Acad. Sci. U.S.A., 105, 3041, 10.1073/pnas.0711741105 · DOI · Paper page
  137. Bollag G., 2010, Nature, 467, 596, 10.1038/nature09454 · DOI · Paper page
  138. Yang H., 2010, Cancer Res., 70, 5518, 10.1158/0008-5472.CAN-10-0646 · DOI · Paper page
  139. Xin B., 2012, Bioorg. Med. Chem. Lett., 22, 4783, 10.1016/j.bmcl.2012.05.053 · doi:10.1016/j.bmcl.2012.05.053
  140. Stellwagen J. C., 2011, Bioorg. Med. Chem. Lett., 21, 4436, 10.1016/j.bmcl.2011.06.021 · doi:10.1016/j.bmcl.2011.06.021
  141. Buck J. R., 2012, Tetrahedron Lett., 53, 4161, 10.1016/j.tetlet.2012.05.137 · doi:10.1016/j.tetlet.2012.05.137
  142. Ryan A. J., 2005, Br. J. Cancer, 92, S6, 10.1038/sj.bjc.6602603 · DOI
  143. Ciardiello F., 2004, Clin. Cancer Res., 10, 784, 10.1158/1078-0432.CCR-1100-03 · DOI · Paper page
  144. Morabito A., 2009, Oncologist, 14, 378, 10.1634/theoncologist.2008-0261 · DOI · Paper page
  145. Hennequin L. F., 2002, J. Med. Chem., 45, 1300, 10.1021/jm011022e · DOI · Paper page
  146. Hennequin L. F., 1999, J. Med. Chem., 42, 5369, 10.1021/jm990345w · DOI · Paper page
  147. Hyttel J., 1992, J. Neural Transm. Gen. Sect., 88, 157, 10.1007/BF01244820 · DOI · Paper page
  148. Sánchez C., 2004, Psychopharmacology, 174, 163, 10.1007/s00213-004-1865-z · DOI
  149. Baumann P., 2002, Eur. Neuropsychopharmacol., 12, 433, 10.1016/S0924-977X(02)00051-2 · doi:10.1016/s0924-977x(02)00051-2
  150. Murdoch D., 2005, Drugs, 65, 2379, 10.2165/00003495-200565160-00013 · DOI
  151. Butler S. G., 2008, Curr. Med. Chem., 15, 1737, 10.2174/092986708784872357 · DOI
  152. Eildal J. N., 2008, J. Med. Chem., 51, 3045, 10.1021/jm701602g · DOI
  153. Zhang P., 2010, J. Med. Chem., 53, 6112, 10.1021/jm1005034 · doi:10.1021/jm1005034
  154. Andersen J., 2010, J. Biol. Chem., 285, 2051, 10.1074/jbc.M109.072587 · DOI
  155. Koldso H., 2010, J. Am. Chem. Soc., 132, 1311, 10.1021/ja906923j · DOI
  156. 1990, Chem. Abstr., 113, 78150
  157. 2009, Chem. Abstr., 150, 144285
  158. 2005, Chem. Abstr., 143, 26491
  159. 2006, Chem. Abstr., 144, 292567
  160. Elati C. R., 2007, Org. Process Res. Dev., 11, 289, 10.1021/op060175e · doi:10.1021/op060175e
  161. 2003, Chem. Abstr., 139, 73997
  162. Solares L. F., 2004, Tetrahedron: Asymmetry, 15, 341, 10.1016/j.tetasy.2003.10.022 · doi:10.1016/j.tetasy.2003.10.022
  163. 2006, Chem. Abstr., 146, 80528
  164. 2007, Chem. Abstr., 147, 211613
  165. Partridge B. M., 2011, Tetrahedron, 67, 10082, 10.1016/j.tet.2011.09.142 · doi:10.1016/j.tet.2011.09.142
  166. Muñoz M., 2012, Expert Opin. Ther. Pat., 22, 735, 10.1517/13543776.2012.697153 · doi:10.1517/13543776.2012.697153
  167. Carletti R., 2005, Eur. J. Neurosci., 21, 1712, 10.1111/j.1460-9568.2005.04002.x · DOI
  168. McLean S., 2005, Curr. Pharm. Des., 11, 1529, 10.2174/1381612053764779 · DOI
  169. Ebner K., 2006, Amino Acids, 31, 251, 10.1007/s00726-006-0335-9 · DOI · Paper page
  170. Humphrey J. M., 2003, Curr. Top. Med. Chem., 3, 1423, 10.2174/1568026033451925 · DOI
  171. Brocco M., 2008, J. Eur. Neuropsychopharmacol., 18, 729, 10.1016/j.euroneuro.2008.06.002 · DOI
  172. Lin P., 2007, Bioorg. Med. Chem. Lett., 17, 5191, 10.1016/j.bmcl.2007.06.085 · doi:10.1016/j.bmcl.2007.06.085
  173. Jiang J., 2009, J. Med. Chem., 52, 3039, 10.1021/jm8016514 · doi:10.1021/jm8016514
  174. Di Fabio R., 2011, J. Med. Chem., 54, 1071, 10.1021/jm1013264 · DOI
  175. Hale J. J., 1998, J. Med. Chem., 41, 4607, 10.1021/jm980299k · DOI · Paper page
  176. Kolla N., 2007, Org. Process Res. Dev., 11, 455, 10.1021/op700030d · doi:10.1021/op700030d
  177. Vankawala P. J., 2007, Synth. Commun., 37, 3439, 10.1080/00397910701487473 · doi:10.1080/00397910701487473
  178. Pye P. J., 2002, Chem.—Eur. J., 8, 1372, 10.1002/1521-3765(20020315)8:6<1372::AID-CHEM1372>3.0.CO;2-6 · doi:10.1002/1521-3765(20020315)8:6<1372::aid-chem1372>3.0.co;2-6
  179. Zhao M. M., 2002, J. Org. Chem., 67, 6743, 10.1021/jo0203793 · doi:10.1021/jo0203793
  180. Cowden C. J., 2000, Tetrahedron Lett., 41, 8661, 10.1016/S0040-4039(00)01548-3 · doi:10.1016/s0040-4039(00)01548-3
  181. Payack J. F., 2004, Org. Process Res. Dev., 8, 256, 10.1021/op034180j · doi:10.1021/op034180j
  182. 2012, Chem. Abstr., 157, 663055
  183. 2009, Chem. Abstr., 151, 343563
  184. Elati C. R., 2007, Tetrahedron Lett., 48, 8001, 10.1016/j.tetlet.2007.09.051 · doi:10.1016/j.tetlet.2007.09.051
  185. Gangula S., 2010, Synth. Commun., 40, 2254, 10.1080/00397910903221084 · doi:10.1080/00397910903221084
  186. Brands K. M. J., 2003, J. Am. Chem. Soc., 125, 2129, 10.1021/ja027458g · DOI · Paper page
  187. Brands K. M. J., 2006, Org. Process Res. Dev., 10, 109, 10.1021/op0501895 · doi:10.1021/op0501895
  188. Nelson T. D., 2004, Tetrahedron Lett., 45, 8917, 10.1016/j.tetlet.2004.09.185 · doi:10.1016/j.tetlet.2004.09.185
  189. Rowley M., 2001, J. Med. Chem., 44, 477, 10.1021/jm0002432 · DOI
  190. Strupczewski J. T., 1995, J. Med. Chem., 38, 1119, 10.1021/jm00007a009 · doi:10.1021/jm00007a009
  191. Citrome L., 2012, Expert Opin. Drug Metab. Toxicol., 8, 873, 10.1517/17425255.2012.693160 · DOI
  192. Rado J., 2010, Expert Opin. Pharmacother., 11, 2087, 10.1517/14656566.2010.502889 · doi:10.1517/14656566.2010.502889
  193. de Leon J., 2012, Expert Opin. Drug Metab. Toxicol., 8, 311, 10.1517/17425255.2012.660918 · DOI
  194. Caccia S., 2010, Drug Des. Devel. Ther., 4, 33, 10.2147/DDDT.S6443 · DOI
  195. 1993, Chem. Abstr., 118, 240939
  196. 2008, Chem. Abstr., 148, 308371
  197. 2011, Chem. Abstr., 155, 123430
  198. 2011, Chem. Abstr., 154, 158482
  199. 2011, Chem. Abstr., 155, 123425
  200. 2012, Chem. Abstr., 157, 548664

200 of 538 shown

Cited by

See all 4,847

Metadata

Authors
Wang, J., Sánchez-Roselló, M., Aceña, J. L., del Pozo, C., Sorochinsky, A. E., Fustero, S., Soloshonok, V. A., & Liu, H.
Venue
Chemical Reviews
Publisher
American Chemical Society (ACS)
Published
2013-12-03
Volume
114
Issue
4
Pages
2432-2506
ISSN
  • 0009-2665 (ISSN-L)
  • 1520-6890
DOI
10.1021/cr4002879
OpenAlex
W2333129245
Cited by
4,847
References
9
FWCI
75.99
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011). https://app.cochat.ai/papers/10.1021/cr4002879
The paper
Wang, J., Sánchez-Roselló, M., Aceña, J. L., del Pozo, C., Sorochinsky, A. E., Fustero, S., Soloshonok, V. A., & Liu, H. (2014). Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011). Chemical Reviews. https://doi.org/10.1021/cr4002879

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.